Remdesivir Shows Promising Results as a Coronavirus Treatment, According to Drug Manufacturer Gilead
https://time.com/5829170/remdesivir-study-results/
Gilead, a California-based biopharmaceutical company, released two encouraging reports about remdesivir, an experimental drug that is being tested as a COVID-19 treatment.
In one statement, the company said that a large study of remdesivir “met its primary endpoint”: meaning, in this case, that the researchers have concluded that hospitalized patients taking the drug appear to improve faster than patients given a placebo.